![](/img/cover-not-exists.png)
The European Medicines Agency review of ipilimumab (Yervoy) for the treatment of advanced (unresectable or metastatic) melanoma in adults who have received prior therapy: Summary of the scientific assessment of the Committee for Medicinal Products for Human Use
Zahra Hanaizi, Barbara van Zwieten-Boot, Gonzalo Calvo, Arantxa Sancho Lopez, Maaike van Dartel, Jorge Camarero, Eric Abadie, Francesco PignattiVolume:
48
Year:
2012
Language:
english
Pages:
243
DOI:
10.1016/j.ejca.2011.09.018
File:
PDF, 347 KB
english, 2012